Medicure (OTCMKTS:MCUJF – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.25), Zacks reports. The company had revenue of $6.13 million for the quarter, compared to analyst estimates of $3.62 million. Medicure had a negative return on equity of 17.91% and a negative net margin of 13.10%.
Medicure Stock Down 22.1%
Shares of Medicure stock opened at $0.75 on Friday. The business has a 50-day moving average price of $0.84 and a 200 day moving average price of $0.84. Medicure has a fifty-two week low of $0.60 and a fifty-two week high of $0.97. The firm has a market cap of $7.83 million, a P/E ratio of -1.53 and a beta of 1.11. The company has a quick ratio of 1.00, a current ratio of 1.44 and a debt-to-equity ratio of 0.03.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Articles
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
